Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Oncology|January 1, 1991
Immunologic changes in renal cell carcinoma patients receiving gamma interferonB P Barna, M J Thomassen, J Sergi, et al.Schizophrenia Research|January 18, 2005
Sensorimotor gating, orienting and social perception in schizophreniaJonathan K Wynn, Mark J Sergi, Michael E Dawson, et al.Journal of Biological Response Modifiers|June 1, 1990
Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanomaM J Caulfield, B Barna, S Murthy, et al.Schizophrenia Research|October 22, 2008
Social cognitive skills training in schizophrenia: an initial efficacy study of stabilized outpatientsWilliam P Horan, Robert S Kern, Karina Shokat-Fadai, et al.Schizophrenia Research|December 5, 2006
Social cognition in schizophrenia: relationships with neurocognition and negative symptomsMark J Sergi, Yuri Rassovsky, Clifford Widmark, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancyG T Budd, S Murthy, J Finke, et al.Journal of Biological Response Modifiers|December 1, 1990
Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effectsR M Bukowski, S Murthy, J Sergi, et al.Environmental Science & Technology|May 12, 2020
Optimizing Emissions Reductions from the U.S. Power Sector for Climate and Health BenefitsBrian J Sergi, Peter J Adams, Nicholas Z Muller, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of WR-2721 and carboplatinG T Budd, R Ganapathi, L Bauer, et al.Cancer Research|November 15, 1989
Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effectsG T Budd, B Osgood, B Barna, et al.Pageof 3